Literature DB >> 21965497

Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation.

A Agustí, B Celli.   

Abstract

Mesh：

Year:  2011        PMID： 21965497     DOI： 10.1183/09031936.00062211

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

1.  Phenotypes of COPD in an Austrian population : National data from the POPE study.

Authors:  Gabriele Reiger; Ralf Zwick; Bernd Lamprecht; Christian Kähler; Otto Chris Burghuber; Arschang Valipour
Journal:  Wien Klin Wochenschr       Date:  2018-05-24       Impact factor: 1.704

Review 2.  Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.

Authors:  Fernando J Martinez; Alvar Agusti; Bartolome R Celli; MeiLan K Han; James P Allinson; Surya P Bhatt; Peter Calverley; Sanjay H Chotirmall; Badrul Chowdhury; Patrick Darken; Carla A Da Silva; Gavin Donaldson; Paul Dorinsky; Mark Dransfield; Rosa Faner; David M Halpin; Paul Jones; Jerry A Krishnan; Nicholas Locantore; Fernando D Martinez; Hana Mullerova; David Price; Klaus F Rabe; Colin Reisner; Dave Singh; Jørgen Vestbo; Claus F Vogelmeier; Robert A Wise; Ruth Tal-Singer; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2022-02-01       Impact factor: 21.405

3.  Persistence of circulating endothelial microparticles in COPD despite smoking cessation.

Authors:  Yael Strulovici-Barel; Michelle R Staudt; Anja Krause; Cynthia Gordon; Ann E Tilley; Ben-Gary Harvey; Robert J Kaner; Charleen Hollmann; Jason G Mezey; Hans Bitter; Sreekumar G Pillai; Holly Hilton; Gerhard Wolff; Christopher S Stevenson; Sudha Visvanathan; Jay S Fine; Ronald G Crystal
Journal:  Thorax       Date:  2016-07-26       Impact factor: 9.139

4.  Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality.

Authors:  Pierre-Régis Burgel; Jean-Louis Paillasseur; Bernard Peene; Daniel Dusser; Nicolas Roche; Johan Coolen; Thierry Troosters; Marc Decramer; Wim Janssens
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

Review 5.  Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities.

Authors:  Pierre-Régis Burgel; Jean-Louis Paillasseur; Nicolas Roche
Journal:  Biomed Res Int       Date:  2014-02-10       Impact factor: 3.411

6.  Natural history of COPD: gaps and opportunities.

Authors:  Alvar Agustí; Bartolomé Celli
Journal:  ERJ Open Res       Date:  2017-12-14

7.  The boundaries of mild chronic obstructive pulmonary disease (COPD): design of the searching clinical COPD onset (SOON) study.

Authors:  Gonzalo Labarca; Andrea Bustamante; Gonzalo Valdivia; Rodrigo Díaz; Álvaro Huete; Paul Mac Nab; Laura Mendoza; Jaime Leppe; Carmen Lisboa; Fernando Saldías; Orlando Díaz
Journal:  BMJ Open       Date:  2017-08-11       Impact factor: 2.692

8.  Phenotypes of COPD patients with a smoking history in Central and Eastern Europe: the POPE Study.

Authors:  Vladimir Koblizek; Branislava Milenkovic; Adam Barczyk; Ruzena Tkacova; Attila Somfay; Kirill Zykov; Neven Tudoric; Kosta Kostov; Zuzana Zbozinkova; Jan Svancara; Jurij Sorli; Alvils Krams; Marc Miravitlles; Arschang Valipour
Journal:  Eur Respir J       Date:  2017-05-11       Impact factor: 16.671

9.  Phenotype and management of chronic obstructive pulmonary disease patients in general population in China: a nationally cross-sectional study.

Authors:  Heling Bao; Guohua Jia; Shu Cong; Wanlu Sun; Jing Fan; Ning Wang; Yajing Feng; Baohua Wang; Jeffrey L Curtis; Linhong Wang; Liwen Fang; Yahong Chen
Journal:  NPJ Prim Care Respir Med       Date:  2021-06-01       Impact factor: 2.871

10.  The EASI model: A first integrative computational approximation to the natural history of COPD.

Authors:  Alvar Agustí; Albert Compte; Rosa Faner; Judith Garcia-Aymerich; Guillaume Noell; Borja G Cosio; Robert Rodriguez-Roisin; Bartolomé Celli; Josep Maria Anto
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.